Navigation Links
Gene Research Sheds Light on Lung Cancer Survival Time
Date:12/15/2010

WEDNESDAY, Dec. 15 (HealthDay News) -- Genes that predict length of survival and help guide treatment for patients with non-small cell lung cancer have been identified by U.S. researchers.

The investigators took samples of lung tumors and nearby healthy lung tissue from 30 patients and examined the samples for the presence of messenger ribonucleic acid (mRNA) associated with 48 known genes for molecules called nuclear hormone receptors.

They then compared the active genes with patient outcomes and found that the expression of genes for certain nuclear hormone receptors helped predict patient survival.

According to the results, patients with two specific nuclear hormone receptors in their tumor tissue lived the longest. The two "biomarkers" were the short heterodimer partner and the progesterone receptor.

"Patient responses to cancer treatment vary widely and often depend on subtle biological differences among tumors," study co-lead author Dr. David Mangelsdorf, chairman of pharmacology at the University of Texas Southwestern Medical Center, said in a facility news release.

"These findings are important because the ability to determine which genes are being expressed in each person's tumor, as well as a patient's likely survival time, can guide physicians to the most effective and appropriate personalized treatments," he added.

The study was published in the Dec. 14 edition of the journal PLoS Medicine.

More information

The American Cancer Society has more about non-small cell lung cancer.

-- Robert Preidt

SOURCE: University of Texas Southwestern Medical Center, news release, Dec. 14, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Breast inflammation is key to cancer growth, Kimmel Cancer Center researchers say
2. Genetic Research Sheds Light on Adrenal Gland Tumor Risk
3. Researchers discover new signaling pathway linked to inflammatory disease
4. UCI researchers find novel memory-enhancing mechanism in brain
5. Cancer Research Institute launches Cancer Vaccine Acceleration Fund
6. States Now Fund Most Embryonic Stem Cell Research in U.S.
7. Researchers make critical leukemia stem cell discovery
8. U-M researchers discover way to block neurodegeneration in an adult form of Fragile X syndrome
9. Leibniz Prize 2011: 10 researchers awarded €2.5 million ($3.3 million) each
10. Research tackles drug use, HIV in South African youth
11. Researchers Turn Stem Cells Into Intestinal Tissue in Lab
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Research Sheds Light on Lung Cancer Survival Time
(Date:1/24/2017)... ... January 23, 2017 , ... The January 2017 issue of the ... study on how outdoor behavioral healthcare (OBH) – also known as wilderness therapy – ... while experiencing an increased sense of purpose both during and after treatment. , ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... a new plugin that allows sleep centers to automatically connect and initialize all ... a thin client browser plugin is quickly installed on first use and then ...
(Date:1/23/2017)... Alto, CA (PRWEB) , ... ... ... a provider of translation and localization services for life science companies, has ... and inspection organization, TÜV SÜD America. ISO 17100 is the globally recognized ...
(Date:1/23/2017)... ... 23, 2017 , ... Wooden and plastic balance boards have been around since at least the ... Board is the first and only balance board to use a patent-pending design featuring ... at the same time as well as skill-level adjustable for all ages and abilities. ...
(Date:1/23/2017)... Indiana (PRWEB) , ... January 23, 2017 , ... ... Center for Assisted Living (IHCA/INCAL), will serve as a healthcare industry expert at ... 23. The panel discussion, moderated by Inside Indiana Business host Gerry Dick, will ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Stock-Callers.com today presents the following Generic ... CPRX ), Sophiris Bio Inc. (NASDAQ: SPHS ), ... Therapeutics Inc. (NASDAQ: AGRX ). These companies are ... late trade on Friday, January 20 th , 2017, with ... of health care companies in the S&P 500 also were ...
(Date:1/23/2017)... , January 23, 2017 The global  anxiety disorders and ... by 2025. The rising incidence of depression worldwide is anticipated to drive the ... resulted in the declining demand for antidepressants in the recent years. ... ... Grand View Research Logo ...
(Date:1/23/2017)... DIEGO and PALMA, Spain ... Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company ... that the first patient has been enrolled in ... lead candidate, SNF472, for the treatment of cardiovascular ... (HD). Most ESRD patients, in the ...
Breaking Medicine Technology: